Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06804109 · ClinicalTrials.gov registry record · NA

Non-invasive Vagus Nerve Stimulation (nVNS) and Cognition in Young Adult Vapers - A Pilot Study

A NA study of Vaping, sponsored by Temple University.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06804109 is a NA study of Vaping that is actively recruiting participants, run by Temple University. The registered enrollment target is 100 participants, below the 755-participant average among 18 other Vaping trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06804109, a NA study of Vaping, is actively recruiting participants, sponsored by Temple University.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the effects of non-invasive vagus nerve stimulation (nNVS) on cognitive functioning in the users of e-cigarettes or vaping products. The investigators will use a digital wellness companion product (TRUVAGA™ device) that provides mild transcutaneous nVNS. The participants will be randomized to receive either a 2-min nNVS stimulation or control stimulation in the neck region followed by completion of three cognitive tests of attention and executive function.

Conditions Studied

Interventions

  • DEVICE Active nVNS
  • DEVICE Control nVNS

Study Locations (1)

Pennsylvania

  • Temple University - Philadelphia

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-03-18
Est. Completion 2028-02-09
Phase NA

Sponsor

Temple University

163 total trials

What the Registry Record Tells You About NCT06804109

The ClinicalTrials.gov registry entry for NCT06804109 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 755-participant average among 18 other Vaping trials with a reported enrollment target (87% lower). The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Vaping appearing as the primary indexed condition, and to 2 interventions - of which Active nVNS is the first listed.

NCT06804109 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06804109 about?

NCT06804109 is a clinical study titled "Non-invasive Vagus Nerve Stimulation (nVNS) and Cognition in Young Adult Vapers - A Pilot Study". The purpose of this study is to assess the effects of non-invasive vagus nerve stimulation (nNVS) on cognitive functioning in the users of e-cigarettes or vaping products. The investigators will use a digital wellness companion product (TRUVAGA™ device) that provides mild transcutaneous nVNS. The pa...

What is the current status of trial NCT06804109?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-03-18. Estimated completion is 2028-02-09.

What conditions does trial NCT06804109 study?

This clinical trial studies the following conditions: Vaping.

What interventions are being tested in trial NCT06804109?

The interventions under investigation include: Active nVNS (DEVICE), Control nVNS (DEVICE).

Who is sponsoring clinical trial NCT06804109?

This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06804109 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Vaping

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.